2-Methyl-5-(2-oxopyrrolidin-1-yl)benzene-1-sulfonyl chloride

Catalog No.: 
ACYTEQ308
CAS No.: 
878433-23-9
Molecular Formula: 
C11H12ClNO3S
Molecular Weight: 
273.74
2-Methyl-5-(2-oxopyrrolidin-1-yl)benzene-1-sulfonyl chloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$262.00InquiryInquiry
250mg95%$467.00InquiryInquiry
1g95%$1831.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Methyl-5-(2-oxopyrrolidin-1-yl)benzene-1-sulfonyl chloride
IUPAC Name2-methyl-5-(2-oxopyrrolidin-1-yl)benzenesulfonyl chloride
MDL No.MFCD07801185
Molecular FormulaC11H12ClNO3S
Molecular Weight273.74
SMILESO=S(C1=CC(N2C(CCC2)=O)=CC=C1C)(Cl)=O
InChI KeyBWTNVYNSLQCXRC-UHFFFAOYSA-N
Synonym2-METHYL-5-(2-OXO-PYRROLIDIN-1-YL)-BENZENESULFONYL CHLORIDE;TIMTEC-BB SBB012174;benzenesulfonyl chloride, 2-methyl-5-(2-oxo-1-pyrrolidinyl;2-methyl-5-(2-oxo-1-pyrrolidinyl)benzenesulfonyl chloride
CAS No.878433-23-9

Synthetic Route by SureRoute

1. ACYTEQ308 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMOAP102 route compound structure diagram
    ACMOAP10269321-56-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYTEQ308 route product structure diagram
    ACYTEQ308878433-23-9
Inquiry

2. ACYTEQ308 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYTEQ308 route product structure diagram
    ACYTEQ308878433-23-9
Inquiry

3. ACYTEQ308 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYTEQ308 route product structure diagram
    ACYTEQ308878433-23-9
Inquiry

Comments (0)